IMNM - Immunome, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$36.20
DETAILS
HIGH:
$40.00
LOW:
$32.00
MEDIAN:
$36.00
CONSENSUS:
$36.20
UPSIDE:
67.13%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 57.4% |
| EBIT Margin | -3084.8% |
| EBITDA Margin | -3042.2% |
| Operating Margin | -3084.8% |
| Pretax Margin | -3060.0% |
| Cont. Ops Margin | -3060.0% |
| Net Margin | -3060.0% |
| Bottom Line Margin | -3060.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 14.69 |
| Quick Ratio | 14.69 |
| Solvency Ratio | -4.288 |
| Cash Ratio | 14.53 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-8.83
Peers avg: 32.9
|
| PEG Ratio | 0.17 |
| Forward PEG | 0.17 |
| Price/Book | 2.96 |
| Price/Sales | 270.32 |
| Price/FCF | -9.35 |
| Price/Op Cash Flow | -9.83 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0056 |
| Debt/Equity | 0.0061 |
| Debt/Capital | 0.0060 |
| Long-Term Debt/Capital | 0.0060 |
| Financial Leverage | 1.08 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.02 |
| Operating Cash Flow Ratio | -4.244 |
| Operating Cash Flow/Sales | -2750.6% |
| Free Cash Flow/Operating Cash Flow | 105.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -49.53 |
| Capital Expenditure Coverage | -19.71 |
| Dividend + Capital Expenditure Coverage | -19.71 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.08 |
| EPS | -2.432 |
| Debt/Share | 0.0441 |
| Cash/Share | 7.48 |
| Book Value/Share | 7.26 |
| Tangible BV/Share | 7.26 |
| Equity/Share | 7.26 |
| Operating Cash Flow/Share | -2.186 |
| Capital Expenditure/Share | 0.111 |
| FCF/Share | -2.297 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.992 |
| Price/Fair Value | 2.96 |
| Debt/Market Cap | 0.0021 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -5.81 |